What is the treatment for Lactobacillus overgrowth (Lactobacilosis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Lactobacillus Overgrowth (Lactobacilosis)

Antibiotic therapy with metronidazole is the first-line treatment for Lactobacillus overgrowth (lactobacilosis), as Lactobacillus species are generally resistant to metronidazole but susceptible to penicillin and vancomycin. 1

Understanding Lactobacilosis

  • Lactobacilli are normally part of the human gastrointestinal and vaginal flora but can occasionally become pathogenic when overgrowth occurs 1
  • Lactobacillus species are taxonomically complex with over 170 species that often require molecular identification for accurate diagnosis 1
  • While lactobacilli are generally considered beneficial and are used in probiotics, overgrowth can lead to clinical symptoms requiring treatment 2

First-Line Treatment Options

  • Metronidazole: Most Lactobacillus species (including L. rhamnosus and L. casei) are resistant to metronidazole, making it an ineffective treatment for lactobacilosis 1
  • Penicillin: L. acidophilus is susceptible to penicillin, making it an effective first-line treatment 1
  • Vancomycin: L. acidophilus shows susceptibility to vancomycin, while L. rhamnosus and L. casei are resistant 1

Antibiotic Susceptibility Profile

  • Lactobacilli are generally resistant to:

    • Aminoglycosides (amikacin, gentamicin, kanamycin, streptomycin) 3
    • Quinolones (ciprofloxacin, norfloxacin, nalidixic acid) 3
    • Sulfonamides (sulphamethoxazole, trimethoprim, co-trimoxazole) 3
    • Cell membrane disruptors (polymyxin B, colistin sulphate) 3
  • Lactobacilli are generally susceptible to:

    • Tetracycline 3
    • Chloramphenicol 3
    • Rifampicin 3

Treatment Algorithm

  1. Confirm diagnosis: Molecular identification is often necessary due to taxonomic complexity 1

  2. First-line treatment:

    • For L. acidophilus overgrowth: Penicillin or vancomycin 1
    • For other Lactobacillus species: Tetracycline, chloramphenicol, or rifampicin 3
  3. Alternative treatments if first-line fails:

    • Consider combination therapy with antibiotics that target cell wall synthesis 3
    • Evaluate for underlying conditions that may predispose to lactobacilosis 2

Special Considerations

  • Antibiotic selection should consider the specific Lactobacillus species involved, as susceptibility patterns vary 1
  • Some Lactobacillus strains (particularly L. plantarum and L. oris) may express resistance to tetracycline and/or doxycycline 4
  • Beta-lactam resistance in lactobacilli appears to be due to cell wall impermeability rather than beta-lactamase production 3

Monitoring and Follow-up

  • Monitor for clinical response within 48-72 hours of initiating antibiotic therapy 1
  • Consider environmental modifications to prevent recurrence after successful treatment 5
  • For recurrent cases, consider longer treatment courses or combination therapy 3

Important Caveats

  • Avoid using probiotics containing the same Lactobacillus species causing the overgrowth during treatment 6
  • In immunocompromised patients, lactobacilosis treatment requires more aggressive management due to increased risk of bacteremia 2
  • The natural resistance of lactobacilli to many antibiotics can make treatment challenging and may require targeted therapy based on susceptibility testing 3

References

Research

Lactobacillus species: taxonomic complexity and controversial susceptibilities.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015

Research

Safety of probiotics that contain lactobacilli or bifidobacteria.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003

Research

Effects of probiotics on the recurrence of bacterial vaginosis: a review.

Journal of lower genital tract disease, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.